Royal Bank Of Canada Tela Bio, Inc. Transaction History

Royal Bank Of Canada

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.39 - $6.36 $3,248 - $4,706	740 Added 13.36%	6,280 $29,000
Q1 2024 Nov 05, 2024	SELL	$5.3 - $7.61 $3,922 - $5,631	-740 Reduced 11.78%	5,540 $31,000
Q1 2024 May 15, 2024	BUY	$5.3 - $7.61 $2,581 - $3,706	487 Added 9.64%	5,540 $31,000
Q4 2023 Feb 14, 2024	BUY	$4.5 - $7.51 $10,282 - $17,160	2,285 Added 82.55%	5,053 $33,000
Q3 2023 Nov 14, 2023	BUY	$7.85 - $10.68 $8,116 - $11,043	1,034 Added 59.63%	2,768 $22,000
Q2 2023 Aug 14, 2023	BUY	$9.23 - $11.23 $13,438 - $16,350	1,456 Added 523.74%	1,734 $17,000
Q1 2023 May 15, 2023	SELL	$9.41 - $12.03 $922 - $1,178	-98 Reduced 26.06%	278 $2,000
Q4 2022 Feb 14, 2023	SELL	$6.5 - $11.5 $4,296 - $7,601	-661 Reduced 63.74%	376 $4,000
Q3 2022 Nov 14, 2022	BUY	$7.36 - $9.15 $272 - $338	37 Added 3.7%	1,037 $9,000
Q3 2021 Nov 15, 2021	SELL	$12.2 - $15.93 $2,562 - $3,345	-210 Reduced 17.36%	1,000 $14,000
Q2 2021 Aug 16, 2021	BUY	$11.7 - $16.11 $14,157 - $19,493	1,210 New	1,210 $19,000

18.3M

759K

100

Ticker TELA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,157,600
Market Cap $51.7M
Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.